ATE145669T1 - T-pa substitutionsvarianten mit verbesserter fibrinspezifität - Google Patents

T-pa substitutionsvarianten mit verbesserter fibrinspezifität

Info

Publication number
ATE145669T1
ATE145669T1 AT93901234T AT93901234T ATE145669T1 AT E145669 T1 ATE145669 T1 AT E145669T1 AT 93901234 T AT93901234 T AT 93901234T AT 93901234 T AT93901234 T AT 93901234T AT E145669 T1 ATE145669 T1 AT E145669T1
Authority
AT
Austria
Prior art keywords
variants
prepared
expression vectors
dna sequences
substitution variants
Prior art date
Application number
AT93901234T
Other languages
English (en)
Inventor
William F Bennett
Bruce A Keyt
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE145669T1 publication Critical patent/ATE145669T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT93901234T 1991-12-16 1992-12-14 T-pa substitutionsvarianten mit verbesserter fibrinspezifität ATE145669T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80812191A 1991-12-16 1991-12-16

Publications (1)

Publication Number Publication Date
ATE145669T1 true ATE145669T1 (de) 1996-12-15

Family

ID=25197925

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93901234T ATE145669T1 (de) 1991-12-16 1992-12-14 T-pa substitutionsvarianten mit verbesserter fibrinspezifität

Country Status (8)

Country Link
EP (1) EP0618973B1 (de)
JP (1) JP3696617B2 (de)
AT (1) ATE145669T1 (de)
AU (1) AU665979B2 (de)
CA (1) CA2124937C (de)
DE (1) DE69215537T2 (de)
NZ (1) NZ246467A (de)
WO (1) WO1993012238A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3112480B2 (ja) * 1991-12-16 2000-11-27 ジェネンテク,インコーポレイテッド 新規な組織プラスミノーゲン活性化因子変異体
DE10153601A1 (de) 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
DE10342518A1 (de) * 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3613390C2 (de) * 1985-04-22 2001-10-11 Genentech Inc Einkettige Human-Gewebeplasminogen-Aktivator (t-PA)-Mutanten, kodierende DNA, Expressionsvektor, Mikroorganismus, Zellkultur und pharmazeutische Zusammensetzung
DK275788A (da) * 1987-05-22 1989-02-03 Zymogenetics Inc Fibrinolytiske proteiner

Also Published As

Publication number Publication date
JP3696617B2 (ja) 2005-09-21
EP0618973B1 (de) 1996-11-27
AU3324293A (en) 1993-07-19
JPH07501946A (ja) 1995-03-02
DE69215537D1 (de) 1997-01-09
NZ246467A (en) 1995-10-26
CA2124937C (en) 2001-06-05
EP0618973A1 (de) 1994-10-12
WO1993012238A1 (en) 1993-06-24
DE69215537T2 (de) 1997-04-30
AU665979B2 (en) 1996-01-25
CA2124937A1 (en) 1993-06-24

Similar Documents

Publication Publication Date Title
Shimokawa et al. Sequence and Biological Activity of Catrocollastatin-C: A Disintegrin-Like/Cysteine-Rich Two-Domain Protein fromCrotalus atroxVenom
IL91306A (en) Tissue plasminogen variant having amino acid substitution in the protease domain having improved zymogenic or fibrin specific properties
HU218831B (hu) Eljárás megnövelt hatású, katalitikus helyre irányuló trombin inhibitorok és ezeket tartalmazó gyógyszer-, és diagnosztikai készítmények előállítására
JPH05500750A (ja) 血小板凝集阻害剤
US5491129A (en) Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them
EP0317053B1 (de) Trigramin, ein Polypeptid, das die Aggregation der Blutplättchen hemmt
FR2581652A1 (fr) Nouveaux mutants de l'activateur tissulaire du plasminogene humain
WO2002048180A3 (de) Peptide und/oder proteine sowie verwendung desselben zur herstellung eines therapeutischen und/oder präventiven arzneimittels
DE69215537D1 (de) t-PA SUBSTITUTIONSVARIANTEN MIT VERBESSERTER FIBRINSPEZIFITÄT
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
Collen et al. Human plasminogen: in vitro and in vivo evidence for the biological integrity of NH2-terminal glutamic acid plasminogen
JPH0647555B2 (ja) フィブリン親和性ウロキナーゼ複合体含有血栓溶解剤
DE69105121D1 (de) Gewebeplasminogenaktivator mit fibrin-spezifischen eigenschaften.
Weinstein et al. Enhancement of rabbit protein S anticoagulant cofactor activity in vivo by modulation of the protein S C4B binding protein interaction.
DE69113049D1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
Cierniewski et al. Localization of the cross‐linking site of GPRVVERHK in the γ‐chain of human fibrinogen
Aronson et al. Human prothrombin fragments FI (αβ) and F2: Preparation and characterization of structural and biological properties
Murakami et al. A cytocidal tissue kallikrein isolated from mouse submandibular glands
DE69105213D1 (de) Substitutionsvariante des gewebeplasminogenaktivators.
JPH0618782B2 (ja) 組織プラスミノーゲン活性化因子製剤
Miyagi et al. Purification of haemorrhagic proteinase from the venom of Agkistrodon caliginosus (Kankoku-Mamushi)
EP0326013A3 (de) Von menschlichem alpha-2-Plasmin-Inhibitor abgeleitete neue Proteine oder Proteine, die diesen ähnlich sind

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification